iShares Genomics Immunology and Healthcare ETF (IDNA)
- Previous Close
24.42 - Open
24.58 - Bid 23.73 x 1100
- Ask 24.64 x 1100
- Day's Range
24.56 - 24.74 - 52 Week Range
17.33 - 25.70 - Volume
29,016 - Avg. Volume
30,004 - Net Assets 142.46M
- NAV 24.38
- PE Ratio (TTM) 2.40
- Yield 1.12%
- YTD Daily Total Return 6.62%
- Beta (5Y Monthly) 1.12
- Expense Ratio (net) 0.47%
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
iShares
Fund Family
Health
Fund Category
142.46M
Net Assets
2019-06-11
Inception Date
Performance Overview: IDNA
View MoreTrailing returns as of 9/26/2024. Category is Health.
People Also Watch
Holdings: IDNA
View MoreTop 10 Holdings (45.24% of Total Assets)
Sector Weightings
Related ETF News
View More
Research Reports: IDNA
View MoreLithium: We Expect a Recovery in 2025
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM is developing a hard rock lithium project in Australia and expanding its lithium refining assets in China.
RatingPrice TargetLithium: We Expect a Recovery in 2025
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants. It is also a major producer of oil refining catalysts.
RatingPrice TargetKey Takeaways From Renewable Energy Conference
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
RatingPrice TargetLithium Americas: General Motors Investment May Come in Alternate Structure
Lithium Americas is a pure-play lithium producer. The firm owns one resource, Thacker Pass, that is located in northwest Nevada. Thacker Pass recently began construction and is expected to begin production in the mid- to late 2020s. Thacker Pass is one of the largest known lithium resources in the world. The project would be the first clay-based asset to enter production, and we estimate it will be in bottom half of the global cost curve. Management plans to develop Thacker Pass into a fully integrated lithium production site, with downstream refining capabilities on site, and will sell into the lithium chemical market.
RatingPrice Target